title: Fluoxetine-induced Ca2+ signals in Madin-Darby canine kidney cells.
abstract: The effect of fluoxetine on Ca2+ signaling in Madin-Darby canine kidney (MDCK) cells was investigated by using fura-2 as a Ca2+ probe. Fluoxetine increased [Ca2+]i concentration-dependently between 5 microM and 200 microM with an EC50 value of 40 microM. The response was reduced by external Ca2+ removal by 30%40%. In Ca2+-free medium pretreatment with 1 microM thapsigargin, an inhibitor of the endoplasmic reticulum Ca2+ pump, abolished 100 microM fluoxetine-induced Ca2+ release. Addition of 3 mM Ca2+ to Ca2+-free medium increased [Ca2+]i when cells were pretreated with 100 microM fluoxetine. Suppression of 1,4,5-trisphosphate (IP3) formation by 2 microM U73122 (a phospholipase C inhibitor) did not affect 100 microM fluoxetine-induced Ca2+ release. Fluoxetine (5-100 microM) also increased [Ca2+]i in neutrophils, prostate cancer cells and bladder cancer cells from human and rat glioma cells.
authors.affiliation: Department of Psychiatry, Kaohsiung Veterans General Hospital, Taiwan.
authors.forename: K Y
authors.initials: KY
authors.lastname: Tang
authors.forename: J S
authors.initials: JS
authors.lastname: Cheng
authors.forename: K C
authors.initials: KC
authors.lastname: Lee
authors.forename: K J
authors.initials: KJ
authors.lastname: Chou
authors.forename: J K
authors.initials: JK
authors.lastname: Huang
authors.forename: W C
authors.initials: WC
authors.lastname: Chen
authors.forename: C R
authors.initials: CR
authors.lastname: Jan
mesh_terms: D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D002118:Calcium / Q000378:metabolism*; D000252:Calcium-Transporting ATPases / Q000037:antagonists & inhibitors / Q000378:metabolism; D002460:Cell Line; D004285:Dogs; D004721:Endoplasmic Reticulum / Q000201:enzymology; D004963:Estrenes / Q000494:pharmacology; D005473:Fluoxetine / Q000494:pharmacology*; D006801:Humans; D015544:Inositol 1,4,5-Trisphosphate / Q000378:metabolism; D007668:Kidney / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D009504:Neutrophils / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D011760:Pyrrolidinones / Q000494:pharmacology; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology*; D019284:Thapsigargin / Q000494:pharmacology; D013997:Time Factors; D014407:Tumor Cells, Cultured
chemical_list: D000255:Adenosine Triphosphate; D002118:Calcium; D000252:Calcium-Transporting ATPases; D004963:Estrenes; D005473:Fluoxetine; D015544:Inositol 1,4,5-Trisphosphate; D011760:Pyrrolidinones; D017367:Selective Serotonin Reuptake Inhibitors; D019284:Thapsigargin; C060229:1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione